CARISMA Therapeutics (NASDAQ:CARM) Stock, Earnings Estimates, EPS, And Revenue

CARISMA Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 7
EPS
$-0.310
Quarterly Revenue
$3.4M
Annual Revenue
(as of Sep 30)
$20.3M

Analyze the earnings history of CARISMA Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

CARISMA Therapeutics (CARM) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-07$-0.31$-0.28-10.7 %
Jun 20242024-08-08$-0.27$-0.3010.0 %
Mar 20242024-05-09$-0.46$-0.43-6.98 %
Mar 20242024-04-01$-0.52$-0.555.45 %

CARISMA Therapeutics (CARM) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-11-07$3.39M$4.97M-31.9 %
Jun 20242024-08-08$9.20M$3.92M134.6 %
Mar 20242024-05-09$3.40M$4.40M-22.8 %
Mar 20242024-04-01$4.29M$2.90M47.9 %

FAQ

Q

When is CARISMA Therapeutics (NASDAQ:CARM) reporting earnings?

A

CARISMA Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for CARISMA Therapeutics (NASDAQ:CARM)?

A

CARISMA Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.31, which missed the estimate of $-0.28.

Q

What were CARISMA Therapeutics’s (NASDAQ:CARM) revenues?

A

CARISMA Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch